Cover Image

The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis

Abstract Purpose Hypoxia is a characteristic of many solid tumours and an adverse prognostic factor for cancer therapy. Hypoxia results in upregulation of carbonic anhydrase IX (CAIX) expression, a pH-regulating enzyme. Many human tissue studies have examined the prognostic value of CAIX expression...

Full description

Saved in:

Bibliographic Details
Main Authors:	Suad A. K. Shamis (Author), Joanne Edwards (Author), Donald C. McMillan (Author)
Format:	Book
Published:	BMC, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Carbonic anhydrase IX as a novel candidate in liquid biopsy
by: Ozen Ozensoy Guler, et al.
Published: (2020)

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
by: Anne E.G. Lenferink, et al.
Published: (2021)

A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors
by: Rakia Abd Alhameed, et al.
Published: (2020)

Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
by: Rita Meleddu, et al.
Published: (2021)

Transmembrane carbonic anhydrase isozymes IX and XII in the female mouse reproductive organs
by: Tomas Eija, et al.
Published: (2004)

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
by: Mehmet Onyılmaz, et al.
Published: (2022)

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
by: Mateusz Kciuk, et al.
Published: (2022)

The inhibitory effect of boric acid on hypoxia-regulated tumour-associated carbonic anhydrase IX
by: Zainab Saad Yusuf, et al.
Published: (2022)

Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action
by: Marco Bragagni, et al.
Published: (2017)

A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
by: Jessica Ruzzolini, et al.
Published: (2020)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
by: Elena Andreucci, et al.
Published: (2019)

The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX
by: Michael Kugler, et al.
Published: (2020)

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
by: Silvia Peppicelli, et al.
Published: (2020)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
by: Ismail Koyuncu, et al.
Published: (2019)

Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma
by: Laura Lucarini, et al.
Published: (2018)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
by: Mikhail Krasavin, et al.
Published: (2020)

Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages
by: Emanuela Berrino, et al.
Published: (2021)

Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
by: Suleyman Akocak, et al.
Published: (2018)

3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII
by: Aleksandrs Pustenko, et al.
Published: (2023)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
by: Zainab M. Elsayed, et al.
Published: (2023)

Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity
by: Mariantonia Logozzi, et al.
Published: (2019)

Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging
by: Zhengxing Zhang, et al.
Published: (2017)

Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro
by: Wong BCK, et al.
Published: (2014)

Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis
by: Alejandro I. Lorenzo-Pouso, et al.
Published: (2020)

Carbonic Anhydrases and Metabolism
by: Supuran, Claudiu T.
Published: (2019)

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
by: Wagdy M. Eldehna, et al.
Published: (2022)

Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line
by: Ismail Koyuncu, et al.
Published: (2019)

Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance
by: Muhammad Umair Amin, et al.
Published: (2022)

Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators
by: Suleyman Akocak, et al.
Published: (2017)

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
by: Chiara Testa, et al.
Published: (2022)

In Silico Identification and Biological Evaluation of Antioxidant Food Components Endowed with Human Carbonic Anhydrase IX and XII Inhibition
by: Giosuè Costa, et al.
Published: (2020)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
by: Mohamed A. Abdelrahman, et al.
Published: (2020)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
by: Sara Seršen, et al.
Published: (2019)

Preclinical evaluation and automated synthesis of [89Zr]ZrDFOSquaramide-girentuximab for diagnostic imaging of carbonic anhydrase IX positive tumours
by: Asif Noor, et al.
Published: (2024)

Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors
by: Belma Zengin Kurt, et al.
Published: (2017)

Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII
by: Davide Ialongo, et al.
Published: (2023)

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
by: Ashraf K. El-Damasy, et al.
Published: (2023)

Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII
by: Shaik Mahammad Ghouse, et al.
Published: (2023)

DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma
by: Heran Ma, et al.
Published: (2021)